Molecular diagnostics firm BillionToOne raises $273.1 million in US IPO-March 2024-www.financetom.com

Molecular diagnostics firm BillionToOne raises $273.1 million in US IPO

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Molecular diagnostics firm BillionToOne raises $273.1 million in US IPO

Nov 5, 2025 7:25 PM

Nov 5 (Reuters) - Molecular diagnostics firm

BillionToOne raised $273.1 million in its U.S. initial public

offering on Wednesday, pricing its shares above its marketed

range at $60 per share.

(Reporting by Bipasha Dey in Bengaluru; Editing by Mrigank

Dhaniwala)

Previous page： Chevron starts operations to boost output in Gulf of Mexico Next page： KKR Secures $2.05 Billion in Financing for Instructure Buyout

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Chevron starts operations to boost output in Gulf of Mexico

Sep 3, 2024

Sept 3 (Reuters) - Chevron ( CVX ) said on Tuesday it had started water injection operations at the company's projects, Jack St. Malo and Tahiti off the U.S. Gulf of Mexico to boost oil and natural gas recovery. ...

KKR Secures $2.05 Billion in Financing for Instructure Buyout

Sep 3, 2024

08:31 AM EDT, 09/03/2024 (MT Newswires) -- KKR & Co ( KKR ) has secured $2.05 billion in loans to finance its buyout of Instructure Holdings ( INST ) , Bloomberg reported Tuesday, citing an unnamed person familiar with the matter. The financing package includes a $1.69 billion first-lien term loan and a $365 million second-lien term loan, Bloomberg reported....

Marimaca Copper Reports Channel Sampling Results From Mercedes Satellite Target in Chile

Sep 3, 2024

08:35 AM EDT, 09/03/2024 (MT Newswires) -- Marimaca Copper ( MARIF ) reported Tuesday additional results from channel sampling completed at the Mercedes satellite target located near the Marimaca oxide deposit in Chile. Highlights include 298 meters at 0.20% total copper, including 10 meters at 1.38% total copper within a broader zone of 80 meters at 0.41% total copper. The...

Vaxcyte Plans Phase 3 Trial for 31-Valent Pneumococcal Conjugate Vaccine Candidate After 'Positive' Phase 1/2 Study Results

Sep 3, 2024

08:31 AM EDT, 09/03/2024 (MT Newswires) -- Vaxcyte ( PCVX ) said Tuesday it plans to launch by mid-2025 a phase 3 study for VAX-31 following positive topline results from a phase 1/2 trial assessing the immunogenicity, safety, and tolerability of the 31-valent pneumococcal conjugate vaccine candidate. The investigational treatment was tested in 1,015 healthy adults aged at least 50...